References
- Brancati F. L., Cusumano A. M. Epidemiology and prevention of diabetic nephropathy. Curr Opin Nephrol Hypertension 1995; 4: 223–229
- Striker G. E., Agoda L. L., Helel P. Kidney disease of diabetes mellitus (Diabetic nephropathy): Perspectives in the United States. J. Diabetic Complications. 1992; 5: 51–58
- Kilaru P., Bakris G. L. Microalbuminuria and progressive renal disease. J Human Hyperten. 1994; 8: 809–817
- Bakris G.L. Microalbuminuria: prognostic implications. Curr Opin Nephrol Hypertension 1996; 5: 219–223
- Cziraky M. J., Mehra I. V., Wilson M. D., Bakris G. L. Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy (Review). Annals of Pharmacol. 1996; 30: 791–801
- Wang P. H., Lan J., Chalmers T. C. Meta-analysis of effects of intensive blood glucose control on late complications of type I diabetes. Lancet 1993; 341: 1306–1309
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Eng J Med. 1993; 329: 977–986
- Dullaart P. P., Beusekamp B. J. Long-term effect of protein restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993; 16: 483
- Anderson S., Rennke H. G., Brenner B. M. Nifedipine versus fosinopril in uninephrectomised diabetic rats. Kidney Int. 1992; 41: 286
- Kasiske B. L., Kalil R., Ma J. Z., Liao M., Keane W. F. Effect of anti-hypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med. 1993; 118: 129–138
- Reichard P., Nilsson B. Y., Rosenquist U. Effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Eng J Med. 1993; 329: 304–309
- Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long term stabilizing effect of ACE inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993; 118: 577–581
- Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Brit Med J. 1991; 362: 210–216
- Chan J. C.N., Cockram C. S., Nieholls M. G., Cheung R., Swaminathan C. K. Comparison of enalapril and nifedipine in treating NIDDM patients associated with hypertension: One year analysis. Brit Med J. 1992; 305: 981–985
- Walker W. G., Hermann J., Anderson J. BP control shows decline of GFR in hypertensive NIDDM patients. J Am Soc Nephrol. 1992; 3: 339–343
- Lebovitz H., Cnaan A. Enalapril shows the progression of renal disease in NIDDM: Results of a 3 year multicenter randomised prospective double blinded study. J Am Soc Neprol. 1992; 3: 335–339
- Bohlen L., De Courten M., Weidmann P. Comparative study of the effect of ACE inhibitors and other anti-hypertensive agents on proteinuria in diabetic patients. Amer J Hyperten. 1994; 7: 84S–92S
- Lewis E. J., Hunsicker L. G., Brian R., Rhode R. D. For the collaborative study group. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engi J Med. 1993; 329: 1456–1462
- Parving H. H., Smidt V. M., Hommel E., Mathiesen E. R., Rossing P., Nielsen F., Mari-Anne G. Effective anti-hypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Disease 1993; 22: 188–195
- Osterby R. Renal pathology in diabetes mellitus. Curr Opin Nephrol Hypertension 1993; 2: 475–483
- Parving H. H., Hommel E., Matheisen E. R. Prevalence of microalbuminuria, arterial hypertension, retiopathy and neuropathy in patients with insulin dependent diabetes. Brit Med J. 1988; 296: 156–159
- Gall M. A., Rossing P., Skott P. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 diabetic patients. Diabetologia 1991; 34: 665–671
- Hostetter T. H. Pathogenesis of Diabetic Glomerulopathy: Hemodynamic considerations. Semin Nephrol. 1990; 16: 219–223
- Morelli E., Loon N., Meyer T., Peters W., Myers B. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76–82
- Wiegmann T. B., Herron K. G., Chonko A. M., Macdougall M. L., Moore W. V. Effect of angiotensin converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes 1992; 41: 62–67